advertiser banner advertiser banner advertiser banner
Digital Issues

Home >  News >  June, 2014

FDA Says More Decisions on Morcellation Coming

The agency will hold a public meeting in July.

Published: June 12, 2014

Will morcellation devices used to laparoscopically remove uterine fibroids be recalled or banned? The FDA is convening a meeting next month to take up the topic.

The agency issued an advisory in April, discouraging their use because the devices can spread cancerous tissue in women with undetected uterine sarcomas, a condition the agency says may affect as many as 1 in every 350 women.

However, proponents of morcellation say the proportion of women with undetected sarcomas is likely closer to 1 in 1,000; that the prognosis is already bleak for those women; and that for everyone else, the alternatives are typically much more dangerous and invasive.

The FDA's Medical Devices Advisory Committee will hold a public meeting on July 10 and 11 and plans to "make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations" for morcellators.

One stock analyst, Greg Chodaaczek of Sterne Agee, says the meeting is likely to result in a so-called black-box warning, saying he doesn't think there's enough data to warrant a recall or ban.

Jim Burger


Also in the News...

Sedate By Day, Pimp By Night
W.Va. Pain Physician Benched For Unsafe Practices
Suit Claims Hospital Altered Consent Form in Disfigured Penis Case
Shooter Opens Fire at Philadelphia-Area Hospital
Plastic Surgeon Faces Malpractice Allegations
Nurse Who Wears Hearing Aids Alleges Job Discrimination
New MH Antidote Can Be Prepared by One Person in One Minute

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?
Airway Management

Protect Apnea Patients With This Disposable CPAP

advertiser banner

Other Articles That May Interest You

Surgeon Gropes Tech in OR

Surgical tech awarded $1.2 million after doc "forcefully" grabbed her breasts.

S.C. Hospital Fined $276.7M for Medicare Fraud

Tuomey's referral-based physician contracts sought to keep cases out of ASCs.

Does Your Insurer Have to Pay to Defend You?

Liability company sues ASC that's been sued by patients.